ABT
Abbott Laboratories · Health Care
4.3%
typical move (median |reaction| of last 8)
—
next expected · no date yet
11
scored events
Last eight reactions
2024-10-16 → 2026-07-16
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-07-16 | pre | +10.7% | 10.7% | +3.8% | +9.0% |
| 2026-04-16 | pre | -6.0% | 6.0% | -4.1% | -17.7% |
| 2026-01-22 | pre | -10.0% | 10.0% | -3.2% | +3.2% |
| 2025-10-15 | pre | -2.4% | 2.4% | -1.6% | -3.2% |
| 2025-07-17 | pre | -8.6% | 8.6% | +3.3% | +4.7% |
| 2025-04-16 | pre | +2.7% | 2.7% | -4.1% | -9.6% |
| 2025-01-22 | pre | +0.9% | 0.9% | +9.3% | +12.4% |
| 2024-10-16 | pre | +1.5% | 1.5% | +0.0% | -4.3% |
Source filings
2026-07-16 · 8-K press release
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance – Second-quarter reported sales growth of 13.0 percent; comparable sales growth of 4.8 percent – Second-quarter GAAP dilute
2026-04-16 · 8-K press release
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences – First-quarter GAAP diluted EPS of $0.61; adjusted diluted EPS of $1.15 reflects growth of 6 perce
2026-01-22 · 8-K press release
Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook – Fourth-quarter GAAP diluted EPS of $1.01; adjusted diluted EPS of $1.50 reflects growth of 12 percent – Full-y
2025-10-15 · 8-K press release
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance – Third-quarter reported sales growth of 6.9 percent; organic sales growth of 5.5 percent or 7.5 percent excluding COVID-19 t
2025-07-17 · 8-K press release
Abbott Reports Second-Quarter 2025 Results – Second-quarter reported sales growth of 7.4 percent; organic sales growth of 6.9 percent or 7.5 percent excluding COVID-19 testing-related sales 1 – Second
2025-04-16 · 8-K press release
9.1 News Release Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance – First-quarter GAAP diluted EPS of $0.76; adjusted diluted EPS of $1.09 – First-quarter reported sales grow
2025-01-22 · 8-K press release
9.1 News Release Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook – Fourth-quarter sales of $11.0 billion; full-year 2024 sales of $42.0 billion – Fourth-quarter
2024-10-16 · 8-K press release
1 News Release Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range – Sales of $10.6 billion driven by strong underlying base business performance – Reported s